Cardiology
🇺🇸 FDAFDA news and analysis for pharmaceutical BD, investment, and market access
Global cardiology market insights for pharma BD, investors & analysts. Track pipeline, M&A, regulatory updates & competitive intelligence.
Showing 1–12 of 21 articles
Quick answer
NovaPharmaNews Cardiology hub for FDA covers 21 published articles — news and analysis for pharma BD, investors, and market access teams. Browse related topics below or explore companies, pipeline, and events linked from each story.
Sanofi pipeline pdf: Dupixent, Lantus and 2026 catalysts
Alnylam pipeline update: AMVUTTRA catalysts, outlook and profitability
Novartis remibrutinib wins Phase 3 in CSU: what it means
ISPOR 2026: Top Cardiology Innovations & Research Highlights
ISPOR 2026: Cardiology Advances in Cost-Effectiveness Research
ISPOR 2026: Cardiology Advances - Day 1 Roundup
THMA Pharmacy Growth Priorities 2026: Key Insights for CPOs
SURPASS-CVOT Trial Results: Implications for Mounjaro's Cardiovascular Safety and FDA Labeling
Adagio Medical's vCLAS Ventricular Ablation System Shows 84% Success Rate in Pivotal Trial for Heart Arrhythmia Treatment
Pulse Biosciences nPulse Cardiac Catheter Shows High Durability in Heart Rhythm 2026 Trial Data
Abbott TactiFlex Duo Ablation Catheter Shows Positive Results for Complex AFib Treatment at Heart Rhythm Society 2026
Medtronic Affera Sphere-9 Catheter Receives FDA Breakthrough Device Designation for Ventricular Tachycardia Treatment
Frequently asked questions
How often is this topic updated?
New articles are published continuously as regulatory, clinical, and commercial signals break. Use the content-type filters for latest news vs in-depth analysis.
Where does this coverage come from?
Editorial intelligence combines FDA openFDA, ClinicalTrials.gov, SEC EDGAR, congress calendars, and analyst reporting. See our data sources policy for attribution.